1 |
王 涛,韩立峰,王跃飞,等. 中成药治疗病毒性肺炎研究进展[J]. 中国中药杂志,2020, 45(7): 1509-1514.
|
2 |
林秀慧,张根生,崔 巍. 病毒性肺炎的诊治进展[J]. 中国现代医生,2017, 55(5): 163-168.
|
3 |
张 涛. 奥司他韦对成人急性重症病毒性肺炎患者炎性因子水平及免疫功能的影响[J]. 中外医药研究,2023, 34(3): 15-17.
|
4 |
肖太平,周 欣,尤惠芳. 乙酰半胱氨酸雾化吸入辅助治疗对病毒性肺炎患者血清炎性因子及T淋巴细胞亚群水平的影响[J]. 中国药业,2023, 32(1): 83-86.
|
5 |
李梦瑶,王 彧,屈 彬,等. 基于文献计量学的病毒性肺炎免疫应答调节机制研究进展分析[J]. 天津中医药大学学报,2023, 42(4): 455-462.
|
6 |
邢 爽,黄海潇,李 明,等. 聚乙二醇干扰素α-1b对荷ACHN肿瘤裸鼠的治疗作用[J]. 中国药物应用与监测,2008, 5(3): 4-7.
|
7 |
宫沛钰,徐 捷,王一捷. 防治病毒性肺炎中连花清瘟胶囊重要靶点DPP4的生物信息学分析[J]. 中国中医基础医学杂志,2023, 29(2): 292-300.
|
8 |
杜 娟,范学杰,陈红梅,等. 甲流H1N1流感病毒性肺炎临床特征及CT影像学表现分析[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 296-300.
|
9 |
Jordan Robert, Shao Matt, Mackman Richard L, et al. Antiviral efficacy of a respiratory syncytial virus (RSV) fusion inhibitor in a Bovine model of RSV infection[J]. Antimicrob Agents Chemother, 2015, 59(8): 4889-4900.
|
10 |
Chen Keping, Jia Runqing, Li Li, et al. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patterns associated with age and season[J]. BMC Public Health, 2015, 15: 113.
|
11 |
Qin S, Zhang W, Chen F, et al. Antibodies against atypical pathogens and respiratory viruses detected by Pneumoslide IgM test in adults with community-acquired pneumonia in Guangzhou City[J]. J Clin Lab Anal, 2020, 34(9): e23419.
|
12 |
Chen A, Song L, Chen Z, et al. Immunoglobulin M profile of viral and atypical pathogens among children with community acquired lower respiratory tract infections in Luzhou, China[J]. BMC Pediatr, 2019, 19(1): 280.
|
13 |
Gao M, Yao X, Mao W, et al. Etiological analysis of virus, mycoplasma pneumoniae and chlamydia pneumoniae in hospitalized children with acute respiratory infections in Huzhou[J]. Virol J, 2020 ,17(1): 119.
|
14 |
Zhan XW, Deng LP, Wang ZY, et al. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia[J]. Ital J Pediatr, 2022, 48(1): 190.
|
15 |
Tjoa E, Joon S, Moehario LH, et al. Identification of Mycoplasma pneumoniae-associated pneumonia cases among hospitalized patients using CLART microarray technology[J]. J Int Med Res, 2022, 50(9): 3000605221123678.
|
16 |
陈瑞芳. 血清LDH、ICAM-1、KL-6水平在病毒性肺炎治疗前后的变化及对近期疗效评估的价值[J]. 华北理工大学学报医学版,2023, 25(4): 283-287.
|
17 |
郑奎生,张丽妍,于进超,等. 病毒性肺炎影像学特征分析[J]. 中国医药科学,2023, 13(13): 153-155.
|
18 |
张瑞珍. 异丙托溴铵联合布地奈德雾化吸入治疗病毒性肺炎的效果分析[J]. 河南医学研究,2017, 26(23): 4342-4343.
|
19 |
梁晓华,黄肇娟. 干扰素α1b联合连花清瘟胶囊治疗呼吸道合胞病毒性肺炎的效果[J]. 深圳中西医结合杂志,2023, 33(10): 36-38.
|
20 |
肖 慧,徐维国,范小兵,等. 血清IL-34、SP-D、CXCL17在甲型流感病毒性肺炎患者中表达及临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(3): 349-351.
|